X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

January 17, 2020

The Latest on Regulations: ICH Guideline to Manage Change throughout the Commercial Lifecycle of Drugs and Combination Products – Part 2

Part 1 of this two part blog series, gave a high-level overview of the new ICH guideline <em>Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management</em>.&nbsp; In part 2 of this blog series, some of the key takeaways will be discussed in more detail.&nbsp; <em>Q12</em> is intended to help companies demonstrate increased product and process knowledge, and understand which post-approval changes will require a regulatory submission, as well as the level of reporting for each category.
Fran DeGrazio

Fran DeGrazio

VP Scientific Affairs and Technical Services

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}